Archive

The New York Medical Angels are willing to provide early-stage funding to companies centered on medical devices, diagnostics, research tools, and drug development. Read article in the Democrat and Chronicle

University of Rochester Medical Center researcher Richard P. Phipps, Ph.D., won a top scientific award from the pharmaceutical giant Novo Nordisk, to collaborate on a new obesity therapy based on his laboratory’s discoveries. Phipps, the Wright Family Research Professor of Environmental Medicine, is the first UR

The Center for Emerging and Innovative Sciences (CEIS) works with companies and universities to advance scientific knowledge, stimulate economies, and make cool stuff happen. Read about a few of their exciting current projects at the Democrat & Chronicle or USA Today.

Reuters has compiled a list of the 100 most innovative universities on the planet. It is no surprise to anyone that Stanford tops that list. Rochester is proud to be included, too. Read the complete story here.

The first issue of UR Ventures Technology Review is out and available here.

The 17 June installment of the Good Advice: Case Studies in Clinical Research, Regulation, and the Law will examine the fascinating history of the COX-2 litigation. Presented by M. Kerry O’Banion, MD, PhD and Thomas Jackson, JD and Immediate Past President of the University of

Camber NeuroTherapeutics Inc., founded based on discoveries made in the laboratories of Harris “Handy” A. Gelbard, M.D., Ph.D. and Stephen Dewhurst, Ph.D., plans to attack the cognitive component of neurodegenerative diseases using a completely new approach: stopping the inflammation in the brain, so-called neuroinflammation, that

Rochester, NY – May 15, 2015 – EagleDream Health, Inc., a healthcare analytics software solutions company today announced it has acquired Focused Medical Analytics, LLC, (FMA) a company specializing in data analysis to identify, understand, and address clinical variation. The acquisition strengthens EagleDream Health’s analytics solution

17 April 2015 CNN Money Panther Biotechnology, Inc. (OTC PINK: PBYA), a biotechnology company specializing in the development of enhanced therapeutics for the treatment of neoplastic disorders, is pleased to announce today that it has entered into an exclusive global license agreement with the University

Outstanding young talents and innovative thinkers from all disciplines up to 35 years of age are invited to apply for an opportunity to present their research project, business plan, entrepreneurial or social initiative that is relevant to the world today — in 3 minutes! More

The SPARK Entrepreneurs club is holding a 24-hour Red Paperclip Challenge for students at all levels of study from Friday, March 20 to Saturday, March 21. Event registration starts at 6:00 p.m. on Friday in the Rettner Hall atrium. The event will kick off with

Research that has transformed scientists’ understanding of the brain and neurodegenerative diseases like Alzheimer’s has been awarded the 2014 Newcomb Cleveland Prize of the American Association for the Advancement of Science (AAAS). The Association’s oldest honor, the prize annually recognizes the author or authors of

Amy Or, Wall Street Journal, 17 December 2014 Norwest Venture Partners’ portfolio company iCardiac Technologies Inc. may have a way to help pharmaceutical companies detect which experimental drugs might flat line over cardiac concerns. The Rochester, N.Y.-based company recently completed a study in collaboration with

Chunlei Guo, professor of optics, is scheduled to be a guest on Science Friday today at 2 p.m. Guo is set to talk about his research on using lasers to create superhydrophobic metals. The show airs on NPR. Tune in locally to WXXI AM1370.

The National Science Foundation today announced that the University of Rochester has been selected for an I-Corps site Award. This 3-year, $300,000 award will give Rochester the resources necessary to support further development of as many as 30 projects per year. Funds may be used